P. Kaviany, J. Senter, J. Collaco, A. Corrigan, E. Brigham, M. Wood, H. Woo, R. Koehl, K. Koehler, N. Hansel, M. McCormack
{"title":"Impact of Tobacco Store Density on Indoor Air Nicotine Levels and Asthma Health in Children with Asthma Living in Baltimore City","authors":"P. Kaviany, J. Senter, J. Collaco, A. Corrigan, E. Brigham, M. Wood, H. Woo, R. Koehl, K. Koehler, N. Hansel, M. McCormack","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3206","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3206","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117115987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Singh, A. Spediacci, C.-W. Wu, J. A. Claude, K. Pinkerton
{"title":"Perinatal Exposure to Secondhand Smoke on Susceptibility to Viral Infection and Bacterial Challenge","authors":"N. Singh, A. Spediacci, C.-W. Wu, J. A. Claude, K. Pinkerton","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3207","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3207","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117204915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Darmawan, K. Gwal, B. Goudy, S. Jhawar, K. Nandalike
{"title":"E-cigarette, or Vaping, Product Use-Associated Lung Injury in Adolescents During COVID-19 Pandemic","authors":"D. Darmawan, K. Gwal, B. Goudy, S. Jhawar, K. Nandalike","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3204","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3204","url":null,"abstract":"Rationale: E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) cases share similar symptomatology to coronavirus disease-19 (COVID-19) making the diagnosis challenging when adolescents present with fever and cough during the COVID-19 pandemic. Methods: In this retrospective chart analysis, we reviewed the clinical, laboratory, and radiographic presentations of teenagers diagnosed with EVALI at UCD Children's Hospital, between February and December 2020. Results: A total of 10 teenagers were hospitalized for EVALI during the study period. The average age was 16.1±0.8 years;40% of patients were female. 40% were Hispanic;40% were Caucasian. Common presenting symptoms included fever (90%), cough (90%), and abdominal symptoms such as nausea, vomiting, and abdominal pain (90%). The laboratory results showed an elevated white blood cell count (18.19±4.1) with neutrophil predominance (88.02±11.3), and elevated C-reactive protein levels (23.5±13.6). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing was done in 9/10 patients and all were negative. Chest radiographs were reported as bilateral opacities (70%), normal (20%), and pneumomediastinum (10% of the cases). Chest computerized tomography, done for 8/10 patients, showed bilateral ground glass opacities in 7/8 patients (Figure 1). With high index of suspicion for EVALI, careful and repeat questioning revealed frequent use of tetrahydrocannabinol vaping products in all cases. The average length of stay was 5±2.7 days;70% needed admission in the pediatric intensive care unit and one patient required intubation. 90% of patients were treated with corticosteroids with a response to treatment within 48 hours. 60% had follow-up in pulmonary clinic, at which point all patients had complete resolution of symptoms. Discussion: Our study shows the similarities in clinical, laboratory, and radiographic findings between EVALI and COVID-19. EVALI cases have decreased since legalization of marijuana, mostly due to reduced use of vitamin E acetate, an adulterant in street products and a common culprit in EVALI cases. However, most of our teenagers obtain vaping products from informal sources and therefore outbreaks continue. There may also be potential for increased EVALI cases secondary to COVID-19 social distancing restrictions. When adolescents present with COVID-19 symptoms, providers should elicit pertinent vaping history. SARS-CoV-2 as well as other appropriate diagnostic work-up should be pursued since EVALI is a diagnosis of exclusion. Early initiation of steroids in EVALI can shorten duration of illness. Appropriate vaping cessation counseling and close outpatient monitoring are needed to reduce the risk of recurrence. 3 of 10 cases were previously published as a case report: https://pubmed.ncbi.nlm.nih.gov/33194204/.","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129917078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vaping and Diffuse Alveolar Hemorrhage: All E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Is Not Created Equal","authors":"N.E. Hoekstra, D. Hinds, K. Dannull, D. Liptzin","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3205","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3205","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"76 20","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120810387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. D. Muise, S. Dahlberg, J. King, T. Martin, A. Casey
{"title":"Effects of Vaping on Lung Function in Adolescents and Young Adults with Respiratory Symptoms","authors":"E. D. Muise, S. Dahlberg, J. King, T. Martin, A. Casey","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3197","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3197","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129796988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. D. Muise, K. Sullivan, R. Gordon, L. Berbert, S. Dahlberg, G. Sawicki, A. Casey
{"title":"Modernizing Pediatric Tobacco Screening on Admission: An Improvement Project Prompted by the EVALI Epidemic","authors":"E. D. Muise, K. Sullivan, R. Gordon, L. Berbert, S. Dahlberg, G. Sawicki, A. Casey","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3203","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3203","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121329975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Presentation, Management and Short-Term Outcomes in Adolescents Hospitalized with Electronic Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)","authors":"B. Abdallah, K. Maple, D. Rao","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3198","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3198","url":null,"abstract":"Rationale: The e-cigarette, or vaping, product use-associated lung injury (EVALI) outbreak peaked in September 2019, yet hospitalization of adolescents for EVALI has continued. We describe the clinical features and short-term pulmonary function outcomes of 36 adolescents hospitalized for EVALI at a large, tertiary-care, university-affiliated children's hospital, including 17 who were treated during the COVID-19 pandemic.Methods: An electronic health record review of adolescents hospitalized at our institution with confirmed or suspected EVALI from December 2018 to December 2020 was conducted. Descriptive statistics were used to characterize sociodemographic data, clinical course, imaging, laboratory results and response to treatment. The Mann-Whitney U test was used to compare pulmonary function test (PFT) results pre- to post- glucocorticoid administration, and also postglucocorticoid to post-discharge.Results: The mean age was 16.3 years;33% were female and 56% were Hispanic. All patients had constitutional symptoms;fever (92%) was the most common. All patients had respiratory (83%) or gastrointestinal (89%) symptoms upon presentation;72% had both. Vaping tetrahydrocannabinol (THC) was reported in 97% and nicotine in 53%. Patients underwent workup or treatment for asthma, typical and atypical pneumonia, appendicitis, sepsis, pulmonary embolism, and respiratory viruses including SARS-CoV-2 before EVALI diagnosis. Urinary THC metabolite was present in 100% of patients tested. Bilateral ground-glass opacities were noted on chest computed tomography (CT) in 97%. Maximal respiratory support of nasal cannula, bi-level positive airway pressure, intubation with mechanical ventilation, or veno-venous extracorporeal membrane oxygenation characterized 18, 4, 4 and 1 patients respectively. SARS-CoV-2 polymerase chain reaction (PCR) testing was positive in 1 out of 17 patients tested;this patient required intensive care and was treated with remdesivir and dexamethasone. Intravenous antibiotics were administered to 69% of patients without subsequent clinical improvement. In contrast, 94% of patients treated with systemic glucocorticoids improved within 24 hours. Median length of hospital stay was 7 days. No patients died. Follow-up CT scan done 1-4 months post-discharge in 5 patients showed complete resolution of ground-glass opacities. A statistically significant improvement (P<0.05) in all pulmonary function measures was observed post-glucocorticoid to post discharge while spirometry and six-minute walk distance also improved pre-and post-glucocorticoid (figure1). Conclusions: Although COVID-19 infection was suspected in many adolescents with EVALI owing to symptom profile overlap, positive SARS-CoV-2 PCR was rare. Imaging findings, clinical symptoms and PFTs improved after glucocorticoid treatment for EVALI.","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127713626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Tackett, T. Islam, M. Rebuli, S. Cwalina, S. Smiley, S. Eckel, A. Leventhal, J. Barrington-Trimis, R. McConnell
{"title":"Adolescent and Young Adult Use of Tobacco and Nicotine Products: Associations with Respiratory Symptoms","authors":"A. Tackett, T. Islam, M. Rebuli, S. Cwalina, S. Smiley, S. Eckel, A. Leventhal, J. Barrington-Trimis, R. McConnell","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3199","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3199","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114847104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Malhotra, D. Gunge, I. Advani, S. Boddu, S. Nilaad, L. C. Crotty Alexander
{"title":"Impact of Age and Inhalant Use on Sleep Latency and Duration in Adolescents","authors":"C. Malhotra, D. Gunge, I. Advani, S. Boddu, S. Nilaad, L. C. Crotty Alexander","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3202","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3202","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124647957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Islam, J. Braymiller, F. Liu, A. Tackett, M. Rebuli, J. Barrington-Trimis, R. McConnell
{"title":"Secondhand Nicotine Vaping and Respiratory Symptoms in Young Adults","authors":"K. Islam, J. Braymiller, F. Liu, A. Tackett, M. Rebuli, J. Barrington-Trimis, R. McConnell","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3208","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3208","url":null,"abstract":"","PeriodicalId":442683,"journal":{"name":"TP68. TP068 TOBACCO PRODUCT EXPOSURES IN PEDIATRIC SUBJECTS","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128050606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}